Scholarlink

Background <p>Choline plays key roles in neurotransmitter synthesis and membrane integrity, processes fundamental to brain function. However, evidence from population studies on the association of dietary choline intake with dementia risk is mixed.</p> Methods <p>We analyzed data of 5,301 dementia-free participants (mean age = 68.6&#xa0;years; 59% females) in the Health and Retirement Study and followed them through 2022. Dietary choline intake was assessed with a validated food frequency questionnaire (2013–2014) and energy-adjusted using the residual method. Incident dementia was identified with the Langa-Weir algorithm. Cox models estimated hazard ratios (HRs) across quintiles of total intake of choline and its contributing components. We additionally conducted a dose–response meta-analysis of existing prospective cohorts using a two-stage random-effects model with restricted cubic splines.</p> Results <p>During follow-up (median = 8.4&#xa0;years, interquartile range: 6.4–8.9&#xa0;years), 506 individuals developed dementia. Total choline intake showed a non-linear association with dementia risk. Compared with the lowest quintile, the multivariable-adjusted HRs (95% CI) for incident dementia across increasing quintiles of total choline were 0.88 (0.66–1.17), 0.87 (0.65–1.17), 0.68 (0.49–0.92), and 0.91 (0.66–1.25) (P-linear-trend: 0.198, P-non-linearity: 0.024). Among choline contributing components, moderate phosphatidylcholine and sphingomyelin intake levels were inversely associated with dementia risk (HR comparing quintile 4 to 1: 0.62, 95%CI: 0.46–0.84 and 0.70, 0.52–0.94, respectively). The meta-analysis of five cohorts (137,607 participants, 2459 dementia cases) showed an L-shaped association of dietary choline intake with dementia risk (P-linear-trend: 0.003, P-non-linearity: 0.036) with a turning point at 465&#xa0;mg/day.</p> Conclusions <p>In this prospective cohort study and dose–response meta-analysis, moderate dietary choline intake was associated with a lower risk of incident dementia in middle-aged and older adults. These findings support further investigation of choline in relation to cognitive aging, particularly the potential non-linear association.</p> Registry for meta-analyses <p>CRD420251151642.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Dietary choline intake and incident dementia in middle-aged and older adults: a prospective cohort study and dose–response meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月30日

查看全文
  • Hui Chen,
  • Tongtong Li,
  • Minyu Wu,
  • Mario H. Flores-Torres,
  • Jie Zheng,
  • Zexin Guo,
  • Jie Yu,
  • Benyan Luo,
  • Dan Liu,
  • Yanhui Lu,
  • Changzheng Yuan

摘要

Background

Choline plays key roles in neurotransmitter synthesis and membrane integrity, processes fundamental to brain function. However, evidence from population studies on the association of dietary choline intake with dementia risk is mixed.

Methods

We analyzed data of 5,301 dementia-free participants (mean age = 68.6 years; 59% females) in the Health and Retirement Study and followed them through 2022. Dietary choline intake was assessed with a validated food frequency questionnaire (2013–2014) and energy-adjusted using the residual method. Incident dementia was identified with the Langa-Weir algorithm. Cox models estimated hazard ratios (HRs) across quintiles of total intake of choline and its contributing components. We additionally conducted a dose–response meta-analysis of existing prospective cohorts using a two-stage random-effects model with restricted cubic splines.

Results

During follow-up (median = 8.4 years, interquartile range: 6.4–8.9 years), 506 individuals developed dementia. Total choline intake showed a non-linear association with dementia risk. Compared with the lowest quintile, the multivariable-adjusted HRs (95% CI) for incident dementia across increasing quintiles of total choline were 0.88 (0.66–1.17), 0.87 (0.65–1.17), 0.68 (0.49–0.92), and 0.91 (0.66–1.25) (P-linear-trend: 0.198, P-non-linearity: 0.024). Among choline contributing components, moderate phosphatidylcholine and sphingomyelin intake levels were inversely associated with dementia risk (HR comparing quintile 4 to 1: 0.62, 95%CI: 0.46–0.84 and 0.70, 0.52–0.94, respectively). The meta-analysis of five cohorts (137,607 participants, 2459 dementia cases) showed an L-shaped association of dietary choline intake with dementia risk (P-linear-trend: 0.003, P-non-linearity: 0.036) with a turning point at 465 mg/day.

Conclusions

In this prospective cohort study and dose–response meta-analysis, moderate dietary choline intake was associated with a lower risk of incident dementia in middle-aged and older adults. These findings support further investigation of choline in relation to cognitive aging, particularly the potential non-linear association.

Registry for meta-analyses

CRD420251151642.